There are truly some intelligent people in society today. These intelligent people extend across all fields of work and cancer treatment is no exception. Have you ever heard of Clay Siegall? If you haven’t, then you’re not alone. Unfortunately, the media doesn’t seem to cover such greatness, but this article will give you a better sense of who this extraordinary guy is. Clay Siegall is one of the industry’s most important figures. He has worked with many of the biggest names in the pharmaceutical industry being Bristol Myers Squibb, the National Institute of Health and the National Cancer Institute. Thanks to having a strong passion for medical research, Siegall has set out to eradicate cancer and this is how.
Siegall is the president and co-founder of Seattle Genetics. This company specializes in the development and commercialization of targeted therapy medications. Seattle Genetics has been around since 1998. Thanks to its consistent growth, innovation and ingenuity, it has become the top cancer research organization in the world. The Seattle-based company has nearly 1,000 staff members, it’s one of the largest employers in the Puget Sound region, and it was visited by former-Vice President Joe bidden a few years ago. Dr. Siegall has stated that the company earns capital in a myriad of ways. This includes selling its very own proprietary drugs, creating production partnerships and providing technology licensing. The company wasn’t earning profits in its early years, but after bringing in an exceptional sales team, the company began to close many lucrative deals.
Of course, none of this happened by chance. Siegall has always done things by the books, but he has also surrounded himself with some of the industry’s most accomplished personnel. Many of the deals were of seven to eight-figures. As of today, Seattle Genetics and Dr. Clay Siegall is the standard by which all others are measured.